Jose E Martinez-Rodriguez
Overview
Explore the profile of Jose E Martinez-Rodriguez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
174
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Munteis E, Vera A, Llop M, Moreira A, Oviedo G, Javierre C, et al.
Mult Scler Relat Disord
. 2024 Apr;
87:105634.
PMID: 38677127
Background: Exercise may have beneficial effects in MS, remaining controversial its possible disease-modifying effects and which mechanisms might be involved. We evaluated whether exercise-induced lymphocyte redistribution differ in MS patients...
2.
Moreira A, Munteis E, Vera A, Macias Gomez A, Recasens B, Rubio Perez M, et al.
Eur J Neurol
. 2022 Mar;
29(7):2015-2023.
PMID: 35247022
Background And Purpose: The aim was to evaluate whether adaptive NKG2C+ natural killer (NK) cells, characterized by enhanced antibody-dependent cell cytotoxicity (ADCC), may influence time to B cell repopulation after...
3.
Lopez-Soley E, Martinez-Heras E, Andorra M, Solanes A, Radua J, Montejo C, et al.
J Pers Med
. 2021 Nov;
11(11).
PMID: 34834459
(1) Background: The evolution and predictors of cognitive impairment (CI) in multiple sclerosis (MS) are poorly understood. We aimed to define the temporal dynamics of cognition throughout the disease course...
4.
Toboso I, Tejeda-Velarde A, Alvarez-Lafuente R, Arroyo R, Hegen H, Deisenhammer F, et al.
Front Neurol
. 2021 Jan;
11:579438.
PMID: 33408681
We assessed the role of age and disease activity as new factors contributing to establish the risk of progressive multifocal leucoencephalopathy in multiple sclerosis patients treated with natalizumab in 36...
5.
Zabalza A, Vera A, Alari-Pahissa E, Munteis E, Moreira A, Yelamos J, et al.
J Neuroinflammation
. 2020 May;
17(1):161.
PMID: 32434524
Background: Human cytomegalovirus (HCMV) infection has been recently associated with a low risk of multiple sclerosis (MS), yet the basis behind this observation remains uncertain. In this study, we aimed...
6.
Moreira A, Alari-Pahissa E, Munteis E, Vera A, Zabalza A, Llop M, et al.
Front Immunol
. 2019 Nov;
10:2403.
PMID: 31681293
Human cytomegalovirus (HCMV) has been recently related with a lower susceptibility to multiple sclerosis (MS). HCMV promotes an adaptive development of NK cells bearing the CD94/NKG2C receptor with a characteristic...
7.
Lopez-Montanes M, Alari-Pahissa E, Sintes J, Martinez-Rodriguez J, Muntasell A, Lopez-Botet M
J Immunol
. 2017 Jun;
199(2):656-665.
PMID: 28630095
NK cells have been reported to respond against EBV-infected B cells in the lytic cycle and to control the viral infection involving IFN-γ secretion. Early reports proposed a role for...
8.
Lopez-Botet M, Muntasell A, Martinez-Rodriguez J, Lopez-Montanes M, Costa-Garcia M, Pupuleku A
Mech Ageing Dev
. 2016 Jun;
158:23-6.
PMID: 27349430
Human cytomegalovirus (HCMV) establishes a highly prevalent life-long latent infection. Though generally subclinical, HCMV infection may have severe consequences during fetal development and in immunocompromised individuals. Based on epidemiological studies...
9.
Martinez-Rodriguez J, Cobo-Calvo A, Villar L, Munteis E, Blanco Y, Rasal R, et al.
Mult Scler
. 2015 Sep;
22(6):741-52.
PMID: 26362897
Background: Human cytomegalovirus (HCMV) causes a highly prevalent infection which may have a multifaceted impact on chronic inflammatory disorders. However, its potential influence in multiple sclerosis (MS) remains controversial. The...
10.
Ortiz M, Nunez C, Ordonez D, Alvarez-Cermeno J, Martinez-Rodriguez J, Sanchez A, et al.
PLoS One
. 2015 Aug;
10(8):e0134414.
PMID: 26274821
Background: Multiple sclerosis (MS) is a neurodegenerative, autoimmune disease of the central nervous system. Genome-wide association studies (GWAS) have identified over hundred polymorphisms with modest individual effects in MS susceptibility...